EUCTR2007-005079-32-AT进行中（未招募）1 期
Treatment of secondary renal amyloidosis A with the Intereleukin – 1 antagonist anakinra
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Biopsy proven renal amyoidosis
- •2.Serum Amyloid A concentration greater than 25mg/l
- •3.Estimated GFR between 30 to 90ml/min
- •4.Men or women aged >18years
- •5.Provision of informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Estimated GFR < 30ml/min
- •2.Kidney disease other than renal amyloidosis
- •3.Child bearing potential with lack of a reliable method of contraception.
- •4.Poor compliance
- •5.Medical history that might limit the individual’s ability to take the trial treatment for the duration of the study.
- •6.Simultanous administration of TNF-blocking agents (etanercept, adalimumab, and infliximab)
研究者
相似试验
招募中
不适用
Clinical assessment of secondary AA amyloidosis associated with rheumatoid arthritisrheumatoid arthritis, AA amyloidosisJPRN-UMIN000003294Aso Iizuka hospital20
招募中
不适用
The clinical assesment of secondary AA amyloidosis assosciated with rheumatoid arthritisRheumatoid arthritis, AA amyloidosisJPRN-UMIN000003296Aso Iizuka hospital20
进行中（未招募）
1 期
AMIND - AMIloride for the treatment of Nephrogenic Diabetes insipidus for patients with bipolar disorder treated with lithium: a randomized controlled trialCTIS2024-515018-42-00Assistance Publique Hopitaux De Paris148
已完成
不适用
Treatment of transthyretin amyloidosis using diflunisaltransthyretin amyloidosisJPRN-UMIN000007508Shinshu University30
已完成
3 期
H8A-MC-LZAZPreclinical ADJPRN-jRCT2080223287Eli Lilly Japan K.K.1,150